A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue

被引:52
作者
Ng, AK
Li, S
Recklitis, C
Neuberg, D
Chakrabarti, S
Silver, B
Diller, L
机构
[1] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA
关键词
cancer survivors; fatigue; Hodgkin's disease; late effects;
D O I
10.1093/annonc/mdi407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To compare the level of fatigue in survivors of Hodgkin's disease and their siblings, and to explore factors associated with increased fatigue. Methods: Survivors of Hodgkin's disease 5 years or more from diagnosis and their siblings completed a questionnaire study. Fatigue level was measured using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) instrument, with lower scores reflecting increased fatigue. Multiple regression models were used to identify factors associated with fatigue level in the two populations. Results: Five hundred and eleven survivors (median age 44 years; range 16-82) and 224 siblings (median age 44 years; range 16-79) returned the completed questionnaire. The response rates were 61% and 58%, respectively. Compared with siblings, survivors were significantly more likely to report the presence of cardiac disease (26% versus 16%; P = 0.001) and hypothyroidism (65% versus 3%; P < 0.001), and had a significantly lower mean FACIT-F score (40.7 and 42.2; P = 0.05). On multivariable analysis, factors significantly associated with increased fatigue in survivors were reports of cardiac disease (P < 0.001), psychiatric condition (P < 0.001), history of tobacco use (P = 0.004) and low exercise frequency (P = 0.03). For siblings, the only independent factor associated with increased fatigue was low exercise frequency (P = 0.03). Conclusions: Survivors of Hodgkin's disease were more fatigued than their siblings. The difference was modest but statistically significant. The significant association between fatigue and cardiac disease suggests the importance of screening for underlying cardiac dysfunction in survivors with symptoms of fatigue. The association between fatigue and smoking history may be due to exacerbation of late medical complications of Hodgkin's disease by tobacco use.
引用
收藏
页码:1949 / 1955
页数:7
相关论文
共 47 条
  • [1] Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy
    Adams, MJ
    Lipsitz, SR
    Colan, SD
    Tarbell, NJ
    Treves, ST
    Diller, L
    Greenbaum, N
    Mauch, P
    Lipshultz, SE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3139 - 3148
  • [2] PSYCHOSOCIAL OUTCOMES OF CANCER - A COMPARATIVE-ANALYSIS OF HODGKINS-DISEASE AND TESTICULAR CANCER
    BLOOM, JR
    FOBAIR, P
    GRITZ, E
    WELLISCH, D
    SPIEGEL, D
    VARGHESE, A
    HOPPE, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (05) : 979 - 988
  • [3] BOIVIN JF, 1992, CANCER, V69, P1241
  • [4] A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease
    Breitbart, W
    Rosenfeld, B
    Kaim, M
    Funesti-Esch, J
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (03) : 411 - 420
  • [5] Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population
    Cella, D
    Zagari, MJ
    Vandoros, C
    Gagnon, DD
    Hurtz, HJ
    Nortier, JWR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) : 366 - 373
  • [6] Fatigue in cancer patients compared with fatigue in the general United States population
    Cella, D
    Lai, JS
    Chang, CH
    Peterman, A
    Slavin, M
    [J]. CANCER, 2002, 94 (02) : 528 - 538
  • [7] The longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from rive randomized clinical trials
    Cella, D
    Kallich, J
    McDermott, A
    Xu, X
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (06) : 979 - 986
  • [8] PERICARDITIS AND MYOCARDIAL INFARCTIONS AFTER HODGKINS-DISEASE THERAPY
    COSSET, JM
    HENRYAMAR, M
    PELLAECOSSET, B
    CARDE, P
    GIRINSKI, T
    TUBIANA, M
    HAYAT, M
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 21 (02): : 447 - 449
  • [9] Dimeo FC, 1999, CANCER, V85, P2273, DOI 10.1002/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>3.0.CO
  • [10] 2-B